A detailed history of Synovus Financial Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Synovus Financial Corp holds 9,017 shares of BDX stock, worth $2.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,017
Previous 8,209 9.84%
Holding current value
$2.03 Million
Previous $1.92 Million 13.3%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $178,947 - $195,867
808 Added 9.84%
9,017 $2.17 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $18,230 - $19,939
-81 Reduced 0.98%
8,209 $1.92 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $255,394 - $271,016
1,094 Added 15.2%
8,290 $2.05 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $757,562 - $842,829
2,972 Added 70.36%
7,196 $1.86 Million
Q2 2023

Aug 08, 2023

BUY
$238.39 - $265.32 $150,900 - $167,947
633 Added 17.63%
4,224 $1.12 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $91,884 - $103,740
-400 Reduced 10.02%
3,591 $888,000
Q4 2022

Feb 06, 2023

BUY
$218.29 - $256.91 $76,183 - $89,661
349 Added 9.58%
3,991 $1.02 Million
Q3 2022

Oct 27, 2022

BUY
$51.03 - $264.23 $1,990 - $10,304
39 Added 1.08%
3,642 $808,000
Q2 2022

Aug 10, 2022

BUY
$234.74 - $275.42 $111,501 - $130,824
475 Added 15.19%
3,603 $890,000
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $52,382 - $58,153
-215 Reduced 6.43%
3,128 $834,000
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $28,760 - $31,367
-125 Reduced 3.6%
3,343 $842,000
Q3 2021

Nov 08, 2021

BUY
$232.72 - $256.47 $7,214 - $7,950
31 Added 0.9%
3,468 $853,000
Q2 2021

Aug 11, 2021

BUY
$232.65 - $254.58 $23,497 - $25,712
101 Added 3.03%
3,437 $836,000
Q1 2021

May 11, 2021

SELL
$232.09 - $256.88 $6,498 - $7,192
-28 Reduced 0.83%
3,336 $811,000
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $27,296 - $30,250
-123 Reduced 3.53%
3,364 $846,000
Q3 2020

Nov 09, 2020

SELL
$215.77 - $276.76 $1,941 - $2,490
-9 Reduced 0.26%
3,487 $811,000
Q2 2020

Aug 10, 2020

SELL
$219.9 - $263.41 $185,155 - $221,791
-842 Reduced 19.41%
3,496 $837,000
Q1 2020

Apr 24, 2020

BUY
$195.69 - $279.01 $224,065 - $319,466
1,145 Added 35.86%
4,338 $997,000
Q4 2019

Feb 06, 2020

SELL
$236.45 - $266.82 $9,458 - $10,672
-40 Reduced 1.24%
3,193 $867,000
Q3 2019

Nov 01, 2019

BUY
$230.58 - $256.08 $1,152 - $1,280
5 Added 0.15%
3,233 $822,000
Q2 2019

Aug 08, 2019

SELL
$217.4 - $246.08 $61,741 - $69,886
-284 Reduced 8.09%
3,228 $813,000
Q1 2019

May 09, 2019

SELL
$206.05 - $248.17 $136,611 - $164,536
-663 Reduced 15.88%
3,512 $876,000
Q4 2018

Feb 07, 2019

BUY
$204.73 - $257.93 $120,381 - $151,662
588 Added 16.39%
4,175 $943,000
Q3 2018

Nov 01, 2018

BUY
$233.07 - $256.0 $466 - $512
2 Added 0.06%
3,587 $938,000
Q2 2018

Aug 01, 2018

BUY
$208.1 - $233.85 $32,463 - $36,480
156 Added 4.55%
3,585 $859,000
Q1 2018

May 07, 2018

SELL
$205.46 - $240.27 $81,156 - $94,906
-395 Reduced 10.33%
3,429 $743,000
Q4 2017

Feb 09, 2018

SELL
$189.0 - $222.64 $93,933 - $110,652
-497 Reduced 11.5%
3,824 $818,000
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $807,551 - $859,446
4,321
4,321 $847,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.